Skip to main content

#151475

Raf KI D486A Mouse

Cat. #151475

Raf KI D486A Mouse

Cat. #: 151475

Sub-type: Mouse

Availability: 8-10 weeks

Disease: Cancer

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Catrin Pritchard

Institute: University of Leicester

Tool Details
Handling
Target Details
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Tool name: Raf KI D486A Mouse
  • Research fields: Cancer;Cell signaling and signal transduction;Genetics;Neurobiology
  • Tool sub type: Mouse
  • Disease: Cancer
  • Conditional: No
  • Description: Knockin of oncogenic Raf-1D486A; in vivo study of oncogenic Raf-1 mutant, and Ras signalling
  • Genetic background: A Raf-1 targeting vector, encoding Raf-1 with a substitution at residue 486 (D to A) and a loxP flanked resistance cassette, was transfected into 129Ola ES cells. Raf-1 was targeted by homologous recombination with the targeting vector. Correctly targeted ES cells were transfected with a Cre expressing vector to excise the resistance cassette, before injection into C57BL/6 blastocysts. Chimeric offspring were bred with C57BL/6 mice to yield mice heterozygous for the mutant allele.
  • Production details: A Raf-1 targeting vector, encoding Raf-1 with a substitution at residue 486 (D to A) and a loxP flanked resistance cassette, was transfected into 129Ola ES cells. Raf-1 was targeted by homologous recombination with the targeting vector. Correctly targeted ES cells were transfected with a Cre expressing vector to excise the resistance cassette, before injection into C57BL/6 blastocysts. Chimeric offspring were bred with C57BL/6 mice to yield mice heterozygous for the mutant allele.

Handling

  • Shipping conditions: Embryo/Spermatoza- Dry Ice

Target Details

  • Target: Raf1 D486A (oncogenic mutant)

References

  • Kamata et al. 2010. Cancer Res. 70(21):8475-86. PMID: 20978199.
  • BRAF inactivation drives aneuploidy by deregulating CRAF.
  • Noble et al. 2008. Mol Cell. 31(6):862-72. PMID: 18922468.
  • CRAF autophosphorylation of serine 621 is required to prevent its proteasome-mediated degradation.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.